Participant consumed grapefruit or grapefruit products and solutions within 3 times prior to the main dose of study drug. - "Our study discovered the vital position from the KLF16/MYC regulatory axis in modulating tumor expansion and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, like OTX015 or ABBV-744, with https://abbv-744cancertreatmentcl02356.sharebyblog.com/31970229/details-fiction-and-clinical-effectiveness-of-abbv-744-in-aml-patients